In order to get in vivo evidences of nanosecond pulsed electric fields (nsPEF) for skin tumor treatment, tumor models in 10 female BALB/c nude mice were established by inoculating them with human melanoma cells A375. These mice were randomly divided into treated group (exposed to nsPEF with intensity of 20 kV/cm and duration of 300 ns) and control group equally. Five days post-nsPEF treatment, tumor growth in the treated group was effectively inhibited (P  0.01 compared with that in control group), typical apoptotic characteristics (DNA damage and fragmentation) were observed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and significant increases in Bax and decreases in Bcl-2, micro-vessel density (MVD), vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) were observed by immunohistochemistry (P  0.01). These experimental results indicate that in vivo tumor growth can be effectively inhibited by nsPEF, which activate two targets, apoptosis initiation and angiogenesis inhibition.
Introduction
Traditionally skin cancers are removed by surgery, which is time consuming and always leaving a scar. Therefore, efforts must be made to find new methods to address skin cancer diseases. successfully used as an effective approach in tumor treatment without using chemotherapeutic drugs.
Another emerging method which uses electric pulses with filed intensity of several tens of kV/cm and duration in the level of nanosecond (nsPEF) has been regarded as a drugfree, non-thermal way to address cancer diseases (9) (10) (11) (12) . Both model evidences and experimental results indicate that nsPEF induce structural and functional changes of intracellular organelles, which is different from traditional electroporation (13-17). Furthermore, nanopores were found in plasma membrane with the application of nsPEF (18) . The bioelectric effects induced by nsPEF on cell structures and subsequent functions may have clinical relevance in cancer treatment. Specifically, nsPEF-induced apoptosis were found in various cancer cell lines in vitro (19) (20) (21) and in B16f10 melanoma tumors in vivo (22) . In addition, several studies indicate that sustained angiogenesis was inhibited by nsPEF (10, 11, (22) (23) (24) . These studies demonstrate that nsPEF offers a promising new therapy for skin tumor treatment.
However, in vivo evidence of nsPEF for skin tumor treatment is still in the beginning stages. In this study, we exposed BALB/c nude mice inoculated with human melanoma cells A375 to nsPEF. In vivo imaging technology was used to trace real-time tumor changes post-nsPEF treatment, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was used to define DNA damage and fragmentation as an apoptosis marker (25) , expressions of Bax and Bcl-2 proteins were investigated by immunohistochemistry (IHC) study, and micro-vessel density (MVD), vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) which define angiogenesis were test by IHC 5 d after nsPEF treatment.
Materials and Methods
Cells A375 cells, a human melanoma cell line (Daping Hospital, Chongqing, China), were cultured with RPMI 1640 (Hyclone, U.S.) medium containing 2% glutamine supplemented with 10% fetal bovine serum and 2% penicillin and streptomycin in a 37°C, 5% CO 2 incubator (Model 2300, SHELLAB, U.S.). The cells were detached by trypsinase and collected by centrifugation (TLL-C, Four-Ring Science Instrument Factory, Beijing, China), washed with physiological saline three times, and suspended with physiological saline at (1.5-2) 3 10 6 cells/mL. Finally, the suspensions were transferred to a 3-mL EP tube.
Lentiviral Transduction Protocol
Add 2 3 10 4 cells in fresh media to the number of wells needed for each construct in a 24-well plate. Triplicate wells for each lentiviral construct and control should be used. Incubate 20 h at 37°C in a humidified incubator in an atmosphere of 5% CO 2 . Then remove media from wells. Add 100 μL media and Hexadimethrine bromide to each well. Gently swirl the plate to mix. Add 10 μL of lentiviral particles (Pslv-CMV-eGFP) to appropriate wells. Gently swirl the plate to mix. Incubate 8 h at 37°C in a humidified incubator in an atmosphere of 5% CO 2 . Remove the media containing lentiviral particles from wells. Add fresh media containing puromycin to a volume of 120 μL to each well. Replace media with fresh puromycin containing media every 3 days until resistant colonies can be identified.
Tumor Formation in Mice
Ten female BALB/c nude mice, 4-6 weeks old, weighting 16-19g , and obtained from the Institute of Zoology Chinese Academy of Sciences, were used in this study. All of them were raised in specific-pathogen-free condition at the Animal Research Center, Chongqing Medical University. These mice were injected beneath the skin on the back (one location per mouse) with 0.1-mL suspension (mentioned in Section A, "Cell Culture"). After implantation, the tumor nodules, psyche, and the diet and defecation of mice were observed every day.
nsPEF Treatment
The nsPEF generator used in this study was designed by our own group, one can refer to (26) for more detail information. This generator has the capability of producing repetitive pulses with a voltage up to 8 kV, pulse width of 200∼1000 ns, rise time of 35 ns, and repetition rate of 1∼1000 Hz with various resistive loads ( Figure 1 ). The voltage was monitored from the output of the nsPEF generator which was connected in parallel with the clamp plate electrodes. These two stainlesssteel parallel plate electrodes, whose diameters were 1 cm, were inserted into the insulation part made from nylon, and the distance between the electrodes can be adjusted to fit the size of the tumor, one can refer to (27) for details. nsPEF with different parameters was used to treat melanoma malignancy in a long-term study (on going) and 1000 pulses of 300 ns and 20 kV/cm were found to completely ablate all tumors with a single treatment. Therefore, 1000 pulses of 300 ns and 20 kV/cm were selected to trace in vivo evidences of nsPEF for melanoma malignancy treatment in a short-term study. These 10 BALB/c nude mice were randomly divided into treated group and control group, five for the treated group and the other five for the control group. The mice in the treated group were exposed to nsPEF with intensity of 20 kV/cm, duration of 300 ns, repeat rate of 1Hz, and pulse number of 1000. The distance between the plate electrodes was measured in every nsPEF treatment case with a vernier caliper. The applied voltage amplitude was calculated with the product of electric-field intensity (20 kV/cm) and the measured distance. Ether inhalation anesthesia was adopted for all of the mice. The mice were covered under an inverted beaker in which a medical sponge dipped with ether was kept. The mice in the control group were not exposed to nsPEF.
In vivo Imaging
All mice in both treated and control groups were epidural anesthansized with pentobarbitone by 40 mg/kg at 0, 24, 48 h and 5 days post-nsPEF treatment. Then the excitation spectrum and emission spectrum of the imaging system (MAE-STRO TM EX Caliper Life Sciences, U.S.) are adjusted to 475 and 509 nm, respectively. In vivo imaging of tumor changes can be obtained by putting the mice in this system. In vivo imaging technology, which is a non-invasive, real-time imaging modality for visualizing small animal anatomy and analyzing function in vivo, is an effective method to trace the viable tumor cells after nsPEF treatment. Therefore, statistical data of GFP-fluorescence obtained by in vivo imaging post-nsPEF treatment can be used to define tumor growth.
TUNEL Assay
Terminal deoxynucleotidyl transferase dUTP nick end labeling assay was done according to the protocol with Apop Tag Red TM in situ (Chemicon, Temecula, CA, USA).
Immunohistochemistry (IHC) Analysis
Frozen sections of both nsPEF-treated and control tumors were processed. 5-μm-thick sections were prepared, airdried for 1 h and fixed with cold acetone (4°C) for 10 min. Slides was then washed with PBS for 4 min and incubated with primary antibodies (Bcl-2, Bax, MVD was identified by incubating sections with anti-mouse CD31 antibody, VEGF, PCNA) for 1 h. The sections were incubated with biotinylated goat anti-rat for Bcl-2, Bax, MVD, VEGF and PCNA for 30 min. The sections were further incubated with an APAAP rat antibody for 30 min. Finally, signal was visualized with Fast Red substrate. Slides were counterstained with Mayer's haematoxylin and mounted with permanent medium. All slides were immunolabelled the same day to ensure standardized intensities of immunochemical signals and counterstaining.
Statistical Analysis
Experimental data were recorded as mean value  standard deviation (SD). Statistical differences between groups were tested with Student's t-test and analysis of variance (ANOVA) (SPSS Statistical Program 15.0; SPSS Inc., Chicage, IL, USA). Differences were considered statistically significant as P  0.05.
Results

In vivo Imaging
As shown in Figures 2 and 3, significant decrease in fluorescence was observed in treated group compare with the control group (P  0.01) at all-time points; significant decrease in fluorescence was also observed in treated group with increasing the time (P  0.05), and no fluorescence was observed 5 days after nsPEF treatment. After euthanasia, tumors were removed from the mice 5 days after nsPEF treatment for the following studies.
TUNEL Assay Results
TUNEL assay was used to study tumor cell apoptosis after nsPEF treatment. As shown in Figure 4 , control group showed blue stained areas indicating the presence of viable tumor cells. In contrast, treated group showed significantly levels of yellow-brown areas indicating the presence of apoptotic cells. Quantitative analyses of tumor cell apoptosis was shown in Figure 5 , significant increase in apoptotic cell percentage was observed compare with the control group 5 days post-nsPEF treatment (P  0.01).
Proteins Expressions of Bax and Bcl-2 5 Days after nsPEF Treatment
Bcl-2 is a family of proteins involved in the response to apoptosis. Bcl-2 protein is antiapoptotic, whereas Bax is proapoptotic. The apoptotic sensitivity of cells to nsPEF can depend on the balance of pro (Bax) and antipoptotic proteins (Bcl-2). We investigated the involvement of Bcl-2 and Bax using IHC on sections from both nsPEF-treated and control tumors. As shown in Figure 6 , yellow-brown staining is a positive indicator for both bax and Bcl-2, treated group showed increased yellow-brown staining in bax and decreased yellow-brown staining in Bcl-2, which demonstrated increased bax and decreased Bcl-2 after nsPEF treatment. We observed an average increase of 247.8% in Bax labeling when comparing 5 nsPEF-treated tumors to 5 control tumors. In contrast, bcl-2, decrease by 57.6% ( Figure  7 ). Both of these changes indicated that nsPEF induced apoptosis in skin tumor cells in vivo.
Micro-vessel Density (MVD), Vascular Endothelial Growth Factor (VEGF) and Proliferating Cell Nuclear Antigen (PCNA) Expressions after nsPEF Treatment
As shown in Figure 8A , control group showed significant level of blue granules indicating the presence of intensive endothelium in neovascular hot spots. In contrast, treated group showed significantly attenuated levels of endothelium. Yellow-brown staining is a positive indicator for both VEGF and PCNA, significantly attenuated levels of yellow-brown granules were observed in both treated groups. Quantitative analyses in Figure 8B showed that MVD of (26.13  2.29) in treated group compare with that of (57.14  10.84) in control group ( Figure 8B) . Both VEGF and PCNA protein expressions decreased after nsPEF treatment compared to controls (P  0.01), with VEGF and PCNA positive rate of (0.3293  0.1155) and (0.3462  0.0388) in treated groups compare to (0.8190  0.0900) and (0.6048  0.0834) in control groups (Figure 8C) , respectively.
Discussion
The application of nsPEF to address skin tumors is a nonthermal, drug-free approach that has several advantages over conventional therapies. Unlike surgery, which is slow and always leaving a scar on the skin, nsPEF can be done is a few minutes and minimal skin scarring caused by initiating apoptosis pathways. Compare with electrochemotherapy and irreversible electroporation, the former involves the introduction of chemotherapeutic agents which have systemic effects, nsPEF are applied locally with cells affected only in a treatment zone that defined by pulse conditions; the latter causes cells death mainly through necrosis, which may cause inflammation.
Previous studies indicated that nsPEF induced apoptosis in B16f10 melanoma tumors in vivo (22) . In addition, several studies indicate that sustained angiogenesis was inhibited by nsPEF (10, 11, 22) . Unlike these studies (11, 22) which applied nsPEF with field intensity of 40 kV/cm to treat skin tumors. nsPEF with different parameters (much lower electric field of 20 kV/cm versus 40 kV/cm) and mouse model (human melanoma cells A375 versus murine melanoma B16-F10 cells) were investigated in our study. Optimization of pulse protocol for tumor treatment has been investigated in (28) , in which a single treatment using the pulse parameters (2000 pulses, 100 ns in duration, 30 kV/cm delivered at 5-7 Hz) caused complete elimination of all tumors. However, the main of this study is to pursuit in vivo evidences of nsPEF for melanoma malignancy treatment and optimization of pulse protocol will be studied in further studies. Lower electric field will greatly reduce electric discharge and skin burns during the application of nsPEF, and this is the biggest advantage of this study compare with that in (11, 22, 28) . 2000 pulses delivered at 1 Hz were used in this study, pulse number is several times of that in (11, 22, 28) , which means that treatment time becomes much longer. In addition, plate electrodes, which can create homogeneous electric field within the tumors and cover the tumors with sufficient electric field, were used in this study. nsPEF can be applied to the targeted tumors non-invasively with the help of plate electrodes. In vivo imaging technology, which is a noninvasive, real-time imaging modality for visualizing small animal anatomy and analyzing function in vivo, was introduced in this study. In vivo imaging technology is an effective method to trace the viable tumor cells after nsPEF treatment, however, further studies are required to demonstrate the indication efficacy of this technology in skin tumor treatment. The absence of fluorescence 5 days after nsPEF treatment would be expected to turn off transcription and translation in any surviving cells, however, this is beyond the scope of our study. The main goal of this is to get in vivo evidences of nsPEF for skin tumor treatment in a short term. Furthermore, our another study ongoing to investigate the long term effect of nsPEF on skin tumor shows that tumor can be completely ablated with the same parameters, which demonstrate the effectiveness of in vivo imaging technology in tracing tumors after nsPEF treatment. In general, our experimental results indicate that no fluorescence was observed in all treated mice 5 days post-nsPEF treatment, demonstrating tumor growth can effectively inhibited by nsPEF. These experimental results are consistent with other previous work in (28) , in which a single treatment using the pulse parameters (2000 pulses, 100 ns in duration, 30 kV/cm delivered at 5-7 Hz) caused complete elimination of all tumors without significant increase in temperature. Assuming that the critical parameter that determined temperature rise is the energy delivered to the tumor, by increasing the pulse length to three times of 100 ns and reducing the field intensity to two thirds of 30 kV/cm, one would expect that each pulse would deliver 4/3 of the energy as in (28) . However, 1000 pulses instead of 2000 pulses of nsPEF were used in this study, which means that the total energy delivered to the tumor is 2/3 of that in (28) . In addition, electrical pulses were delivered at 1 Hz in this study, much lower than that in (28) . In a simulation study by Lackovic et al. (29) , Joule heating of high voltage (8 pulses of 1500 V/cm and 100 microsecond delivered at a repetition rate of 1Hz) with plate electrodes was calculated, no heating was found. The energy of each pulse in our study is much smaller than that in (29). Therefore, temperature increases during nsPEF treatment in our study is negligible.
The unique aspect of this study is that in vivo imaging of GFP expression was used to predict the outcome of nsPEF treatment at first, and no fluorescence was observed 5 days after nsPEF-treatment, then all mice were euthanatized, and tumors were removed for TUNEL and IHC studies. The results of TUNEL study showed that significant increases in percentage of apoptotic cell were observed after nsPEF treatment, which was in agreement with the previous studies (22) . In addition, significant increase in Bax and decrease in Bcl-2 were observed by IHC, which suggest nsPEF initiates apoptosis in tumor cells in vivo. In vivo apoptosis marker after nsPEF treatment has been studied in (11, 22) , in which caspase activation, DNA changes, increases in Bad, and decreases in Bcl-2 were observed post-nsPEF treatment. They have shown that transient expression of real apoptosis markers (caspase activation, DNA changes, increases in Bad, and decreases in Bcl-2 ) can be identified within the first hours after treatment and to be decreasing or absent several hours after treatment, this may change with different tumor models and lower nsPEF parameters applied. Therefore, the time required for apoptosis may be greatly different than that in (22) and apoptotic markers can be indentified even 5 days after nsPEF treatment. The main goal of our study is to purse in vivo evidences instead of mechanisms of nsPEF for skin tumor treatment, therefore, only TUNEL and IHC study were performed to get apoptosis evidences with application of nsPEF.
Another major target for nsPEF in skin tumor treatment is angiogenesis inhibition, which has been investigated in (10, 11, 22) . These studies indicate that angiogenesis was inhibited 7 days post-nsPEF treatment. Unlike the study in (22) , decreases in micro-vessel density (MVD), vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) were observed 5 days after nsPEF by IHC, and the results showed that angiogenesis was inhibited even with much lower electric field intensity of 20 kV/cm. In addition, the size of tumors treated by nsPEF is neither too large nor too small, too large will cause electric discharges and skin burns, and tumors cannot be ablated completely by one-time treatment; too small is difficult for the operation of nsPEF treatment and electrodes will often slip during the treatment because of muscle contraction. In this study, the size of the tumors is averaged 6-8 mm in diameter. To obtain a field intensity of 20 kV/cm, the distance between the two plate electrodes was adjusted to 3-4 mm and nsPEF with amplitude of 6-8 kV were applied.
In general, as an emerging approach in skin tumor treatment, nsPEF has many advantages over traditional methods: it is very fast, drug-free, 100% effective. However, a lot of in vivo studies have to be done before applying nsPEF in skin tumor treatment. Optimization of parameters of nsPEF in murine malignant melanomas treatment were perform in (28) , with a single treatment using 2000 pulses of 100 ns and 30 kV/cm delivered at 5-7 Hz caused complete remission of all tumors. However, further optimization studies dealing with different tumor types and electrode configurations have to be performed. In addition, only apoptosis initiation and angiogenesis inhibition were investigated in our study, other melanomas targets that may be recruited by using nsPEF have to be studied in further researches.
Conclusion
In this study, we introduced in vivo imaging technology to investigated tumor changes after nsPEF treatment, which showed that effectively inhibition of tumors can be obtained on day 5 post-nsPEF treatment. Then two major targets for nsPEF in skin tumor treatment were investigated by TUNEL and IHC studies, demonstrating that both apoptosis initiation and angiogenesis inhibition were recruited in nsPEF-induced cell death.
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